Neumora Therapeutics(NMRA) - 2024 Q3 - Earnings Call Transcript

Neumora Therapeutics, Inc. (NASDAQ:NMRA) Q3 2024 Earnings Conference Call November 12, 2024 8:00 AM ET Company Participants Helen Rubinstein – Vice President of Investor Relations Henry Gosebruch – President and Chief Executive Officer Josh Pinto – Chief Financial Officer Rob Lenz – Head of Research and Development Conference Call Participants Julian Pino – Stifel Brian Abrahams – RBC Capital Markets Myles Minter – William Blair Charles Wang – Mizuho Douglas Tsao – H.C. Wainwright Charlie Yang – Bank of Ame ...